Farmako logo
HomeMedicine DeliveryABDM
Decorative illustration
HomeMedicine DeliveryABDM
footer illustration
Home
About UsRefund & CancellationProduct / Service Details
Contact UsDelivery & Shipping PolicyPrivacy Policy
Download the App
play-storeapp-store
Copyright Farmako Healthcare Private Limited © 2025 All rights reserved
facebooktwitterlinkedininstagram
medicine
medicine
medicine

Eurolide 3.75mg Depot Injection

vial of 1.0 Injection
Prescription Required
30 minute delivery
vial of 1.0 Injection
₹ 2175.65
Get it on upto a 20% discount on Farmako
Delivering to
Out of Stock
Ask Life AI anything about this medicine
Tell me about medicines!

Manufacturer

Samarth Life Sciences Pvt Ltd

Salt Composition

Leuprolide (3.75mg)

Key InformationDirections for UseHow it worksQuick Tips

Manufacturer

Samarth Life Sciences Pvt Ltd

Salt Composition

Leuprolide (3.75mg)

Key Information

Short Description

Eurolide 3.75mg Depot Injection is used to treat prostate cancer, endometriosis, uterine fibroids, and central precocious puberty.

Dosage Form

Injection

Introduction

Eurolide 3.75mg Depot Injection is used in the treatment of prostate cancer. It is also used to treat endometriosis (endometrium of the uterus grows excessively and causes symptoms like pain, heavy or irregular periods), uterine fibroids and central precocious puberty (very early puberty).

Directions for Use

Your doctor or nurse will give you this medicine. Kindly do not self-administer.

How it works

Eurolide 3.75mg Depot Injection reduces the amount of sex hormones (testosterone in men and estrogen in women)..It works by decreasing the blood levels of testosterone in males..Eurolide 3.75mg Depot Injection also acts by shutting off hormones made by the ovaries (female reproductive organs) so the estrogen (one of the hormones that causes females to have periods) level is lowered.

Quick Tips

Eurolide 3.75mg Depot Injection helps in the treatment of locally advanced or metastatic prostate cancer. It may also be used to treat endometriosis and uterine fibroids. It is given as an injection either under the skin or into a muscle. It may cause dizziness and visual disturbances. Don't drive or do anything that requires mental focus until you know how it affects you. Long term treatment may lead to bone loss and a higher risk of bone fractures especially if you are a heavy drinker, a smoker, or have a family history of osteoporosis.

Short Description

Eurolide 3.75mg Depot Injection is used to treat prostate cancer, endometriosis, uterine fibroids, and central precocious puberty.

Dosage Form

Injection

Introduction

Eurolide 3.75mg Depot Injection is used in the treatment of prostate cancer. It is also used to treat endometriosis (endometrium of the uterus grows excessively and causes symptoms like pain, heavy or irregular periods), uterine fibroids and central precocious puberty (very early puberty).
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Eurolide 3.75mg Depot Injection reduces the amount of sex hormones (testosterone in men and estrogen in women)..It works by decreasing the blood levels of testosterone in males..Eurolide 3.75mg Depot Injection also acts by shutting off hormones made by the ovaries (female reproductive organs) so the estrogen (one of the hormones that causes females to have periods) level is lowered.
Eurolide 3.75mg Depot Injection helps in the treatment of locally advanced or metastatic prostate cancer. It may also be used to treat endometriosis and uterine fibroids. It is given as an injection either under the skin or into a muscle. It may cause dizziness and visual disturbances. Don't drive or do anything that requires mental focus until you know how it affects you. Long term treatment may lead to bone loss and a higher risk of bone fractures especially if you are a heavy drinker, a smoker, or have a family history of osteoporosis.

Frequently asked questions

Is Eurolide 3.75mg Depot Injection a chemotherapy medicine or hormone analogue?

No, Eurolide 3.75mg Depot Injection is not a chemotherapy medicine but rather a synthetic hormone analogue used for the treatment of hormone-dependent conditions in men and women.

What effect does Eurolide 3.75mg Depot Injection have on menstrual cycles?

While taking Eurolide 3.75mg Depot Injection, periods tend to stop as this medication alters reproductive hormones in females. In some cases, vaginal bleeding may occur; it is essential to consult your doctor for assessment and guidance.

Is Eurolide 3.75mg Depot Injection a hormonal medicine and can it be used during pregnancy?

Yes, Eurolide 3.75mg Depot Injection is a hormonal medication that affects reproductive hormones in females. This treatment is not recommended for use in women who are or may become pregnant as it can harm the fetus. Using this medicine during pregnancy may also lead to miscarriage.

Can Eurolide 3.75mg Depot Injection affect bone density?

Yes, there is a possibility of Eurolide 3.75mg Depot Injection affecting bone mineral density, making bones weaker. In women, especially those at increased risk of osteoporosis, bone density should be assessed before starting the treatment and appropriate measures taken if necessary.

Is Eurolide 3.75mg Depot Injection linked to diabetes or high blood sugar?

Yes, Eurolide 3.75mg Depot Injection may cause an increase in blood sugar levels, potentially worsening glucose control in patients with diabetes. It can also increase the risk of developing diabetes. Regular monitoring of blood glucose and/or glycosylated hemoglobin (HbA1c) is recommended.

No, Eurolide 3.75mg Depot Injection is not a chemotherapy medicine but rather a synthetic hormone analogue used for the treatment of hormone-dependent conditions in men and women.
While taking Eurolide 3.75mg Depot Injection, periods tend to stop as this medication alters reproductive hormones in females. In some cases, vaginal bleeding may occur; it is essential to consult your doctor for assessment and guidance.
Yes, Eurolide 3.75mg Depot Injection is a hormonal medication that affects reproductive hormones in females. This treatment is not recommended for use in women who are or may become pregnant as it can harm the fetus. Using this medicine during pregnancy may also lead to miscarriage.
Yes, there is a possibility of Eurolide 3.75mg Depot Injection affecting bone mineral density, making bones weaker. In women, especially those at increased risk of osteoporosis, bone density should be assessed before starting the treatment and appropriate measures taken if necessary.
Yes, Eurolide 3.75mg Depot Injection may cause an increase in blood sugar levels, potentially worsening glucose control in patients with diabetes. It can also increase the risk of developing diabetes. Regular monitoring of blood glucose and/or glycosylated hemoglobin (HbA1c) is recommended.
India' first 30 minutes
medicine delivery service
percentage
Get atleast 20% discount on all medicines
shield
We always ensure genuine medicines and qualified doctors
deliver
Completed over 2 lakhs super-fast deliveries